Outcomes in Hospitalized Older Patients With COVID-19

In December 2019, the first patients infected with the 2019 novel coronavirus (2019-nCoV) were diagnosed in Wuhan. The clinical presentation and course of Severe Acute Respiratory Syndrome-CoV-2 (SARS-CoV-2) infection is poorly understood in older patients and is certainly different from the general population. This project is designed to better understand and to determine clinical, biological and radiological markers of poor adverse outcomes in hospitalized older patients diagnosed with COVID-19.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Coronavirus Infection Coronaviridae Infections Coronavirus Infections Elderly Infection Frailty Infections Nidovirales Infections Old Age; Debility Pathologic Processes Pathological Conditions, Signs and Symptoms RNA Virus Infections Sars-CoV2 Virus Diseases

Age range

65 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Rehabilitation and Geriatrics

Geneva, 1256, Switzerland

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Diagnosis of COVID-19, defined by a positive polymerase chain reaction (PCR) test for SARS-CoV-2 detection, obtained by a nasopharyngeal swab or sputum sample.
Or patients with negative virus detection in the PCR test, but with a high clinical suspicion will also be considered with COVID-19.

Exclusion criteria

Presence of document indicating a refusal to participate in a research study.

Treatment and study plan

Primary outcomes

To evaluate the relative contributions of comorbidities on intra-hospitalized death

Time frame: 1 month

We measure functional score of comorbidities

Secondary outcomes

To evaluate the relative contributions of functional characteristics on intra-hospitalized death

Time frame: 1 month

We measure Functional Independence Measure scale
To explore specific clinical profiles that may influence COVID-19 disease outcomes in the elderly based on geriatrics syndromes

Time frame: 1 month

We describe the role fo geriatric syndrome such as delirium, falls

Sponsors and collaborators

Lead sponsor

University Hospital, Geneva

Other

Registry information

Official study title

COVIDAge Study- Hospital Des Trois-Chêne

Important dates

Study start: 2020
Primary completion: 2020
Study completion: 2020
First posted: May 12, 2020
Registry last updated: May 12, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed